Triple-Digit Oil, an Airman's Worst Friday, and a Market That Keeps Absorbing Punches

Triple-Digit Oil, an Airman's Worst Friday, and a Market That Keeps Absorbing Punches

Mar 13, 2026
Oil Hits Triple Digits, a Hormuz Standoff, and Stocks Take the Punch

Oil Hits Triple Digits, a Hormuz Standoff, and Stocks Take the Punch

Mar 12, 2026
Oracle Proves AI Is Real, Papa John's Gets a Buyout Bite, and Oil Won't Sit Still

Oracle Proves AI Is Real, Papa John's Gets a Buyout Bite, and Oil Won't Sit Still

Mar 11, 2026
Rare Disease Rockets, A Pharma Buyout Lands, and Railcars Hit a Wall

Rare Disease Rockets, A Pharma Buyout Lands, and Railcars Hit a Wall

Mar 10, 2026
Nasdaq Leads Rebound, Biotech Sees Breakouts, and Telehealth Scores Weight-Loss Win

Nasdaq Leads Rebound, Biotech Sees Breakouts, and Telehealth Scores Weight-Loss Win

Mar 9, 2026
Pain at the Pump, Pain in the Payrolls, and One Biotech Gets Paid

Pain at the Pump, Pain in the Payrolls, and One Biotech Gets Paid

Mar 6, 2026
Oil's Second Wind, a Grocery Gutting, and an Ethanol Glow-Up

Oil's Second Wind, a Grocery Gutting, and an Ethanol Glow-Up

Mar 5, 2026
Iran Talks, Bitcoin Bounce, and Big Tech Back in the Driver's Seat

Iran Talks, Bitcoin Bounce, and Big Tech Back in the Driver's Seat

Mar 4, 2026
Oil Rallies Extend, Asset Sales Unlock Value, and Margin Pressure Hits AI Play

Oil Rallies Extend, Asset Sales Unlock Value, and Margin Pressure Hits AI Play

Mar 3, 2026
Oil Shock Ignites Small Caps, Biotech Deal Fever Spreads, and Safety Concerns Slam a Drug Maker

Oil Shock Ignites Small Caps, Biotech Deal Fever Spreads, and Safety Concerns Slam a Drug Maker

Mar 2, 2026
Buyout Premiums Ignite IoT, AI Demand Lifts Optics, and Cash Burn Batters Solar

Buyout Premiums Ignite IoT, AI Demand Lifts Optics, and Cash Burn Batters Solar

Feb 27, 2026
Earnings Blowouts Spark Euphoria, Guidance Fuels Optimism, and Profit Warnings Crush Clean Energy

Earnings Blowouts Spark Euphoria, Guidance Fuels Optimism, and Profit Warnings Crush Clean Energy

Feb 26, 2026
Breakthrough Designation Lifts Biotech, Takeover Interest Surfaces, and Ad Disruption Rattles Retail

Breakthrough Designation Lifts Biotech, Takeover Interest Surfaces, and Ad Disruption Rattles Retail

Feb 25, 2026
Phase 3 Success Sparks a Biotech Rally, AI Capacity Expands, and Earnings Misses Shake Confidence

Phase 3 Success Sparks a Biotech Rally, AI Capacity Expands, and Earnings Misses Shake Confidence

Feb 24, 2026
Takeovers Spark Surge, an FDA Approval Adds Firepower, and Trial Data Derails Pharma

Takeovers Spark Surge, an FDA Approval Adds Firepower, and Trial Data Derails Pharma

Feb 23, 2026
Cloud Earnings Impress, Diabetes Devices Gain Ground, and a Trial Miss Sinks Biotech

Cloud Earnings Impress, Diabetes Devices Gain Ground, and a Trial Miss Sinks Biotech

Feb 20, 2026
A Site Expansion Fuels Breakout, Fintech Turns Profitable, and EV Write-Downs Shake Earnings

A Site Expansion Fuels Breakout, Fintech Turns Profitable, and EV Write-Downs Shake Earnings

Feb 19, 2026
Oncology Funding Ignites, EU Approval Expands Reach, and Tech Volatility Pressures Chips

Oncology Funding Ignites, EU Approval Expands Reach, and Tech Volatility Pressures Chips

Feb 18, 2026
Chip-Tech Momentum Builds, Buyout Premium Lifts Stock, and Dilution Fears Hit Construction

Chip-Tech Momentum Builds, Buyout Premium Lifts Stock, and Dilution Fears Hit Construction

Feb 17, 2026
Engineered Crops Break Out, Gaming Margins Expand, and an AI Debut Stumbles

Engineered Crops Break Out, Gaming Margins Expand, and an AI Debut Stumbles

Feb 13, 2026
Cloud and Laser Earnings Shine, Machine Vision Finds Momentum, and a Biotech Pivot Shakes Confidence

Cloud and Laser Earnings Shine, Machine Vision Finds Momentum, and a Biotech Pivot Shakes Confidence

Feb 12, 2026
Ad-Tech Delivers a Breakout Quarter, Aerospace Finds Its Lift, and Biotech Data Fails to Impress

Ad-Tech Delivers a Breakout Quarter, Aerospace Finds Its Lift, and Biotech Data Fails to Impress

Feb 11, 2026
Drug Trial Wins Drive Gains, Margins Crack in Transport, and Freelance Platforms Can’t Bill Enough

Drug Trial Wins Drive Gains, Margins Crack in Transport, and Freelance Platforms Can’t Bill Enough

Feb 10, 2026
Drilling Consolidation Drives Gains, Cancer Research Moves Ahead, and Accounting Woes Shake Tech

Drilling Consolidation Drives Gains, Cancer Research Moves Ahead, and Accounting Woes Shake Tech

Feb 9, 2026
Heart Rhythm Data Excites, Fintech Momentum Builds, and Earnings Misses Hammer Cyclicals

Heart Rhythm Data Excites, Fintech Momentum Builds, and Earnings Misses Hammer Cyclicals

Feb 6, 2026
Load more